New obesity drug BGM0504 tested for interactions with metformin and warfarin
NCT ID NCT06920056
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed Phase 1 trial tested how a new injectable drug, BGM0504, affects stomach emptying and the absorption of two common medications—metformin and warfarin—in 28 overweight or obese adults. Participants received BGM0504 alongside these drugs to measure changes in drug levels in the blood. The goal was to gather safety and interaction data, not to treat obesity directly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BGM0504
What this could lead to
If successful, this could help doctors understand how BGM0504 interacts with common medications, guiding safer use in people with obesity.
What could go wrong
This is an early Phase 1 trial with only 28 participants, focused on drug interactions rather than treatment outcomes. Results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine)
Kunming, Yunnan, 650100, China